Algorae Pharmaceuticals Limited (ASX:1AI)
0.0060
+0.0010 (20.00%)
At close: Jul 25, 2025, 4:00 PM AEST
Algorae Pharmaceuticals Revenue
Algorae Pharmaceuticals had revenue of 125.20K AUD in the twelve months ending December 31, 2024, up 197.98% year-over-year. In the fiscal year ending June 30, 2024, Algorae Pharmaceuticals had annual revenue of 125.20K with 197.98% growth.
Revenue
125.20K
Revenue Growth
+197.98%
P/S Ratio
80.87
Revenue / Employee
2.61K
Employees
48
Market Cap
10.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 125.20K | 83.18K | 197.98% |
Jun 30, 2023 | 42.02K | 38.61K | 1,133.95% |
Jun 30, 2022 | 3.41K | -264.78K | -98.73% |
Jun 30, 2021 | 268.18K | -285.51K | -51.56% |
Jun 30, 2020 | 553.69K | -215.99K | -28.06% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |